Documents & Downloads

Evazarsen sodium

Angiotensinogen Synthesis Inhibitor

Evazarsen sodium is an angiotensinogen synthesis inhibitor that exhibits antihypertensive properties. By targeting the synthesis of angiotensinogen, it plays a significant role in regulating blood pressure and can be utilized in research related to cardiovascular diseases and hypertension management. This compound is valuable for studies focusing on the molecular mechanisms of blood pressure regulation and the development of potential therapeutic interventions.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2589926-24-7
Applications	Angiotensinogen Synthesis Inhibitor
Formula	C₂₉₆H₄₁₄N₈₆O₁₄₆P₂₀S₁₉Na₂₀
Molecular Weight	8761.8 (free acid)
Synonyms	ISIS-757456 sodium

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.